Natco Pharma Limitedannounces that the U.S. Food and Drug Administration has granted approval to its partner Breckenridge Pharmaceutical Inc’s Abbreviated New Drug Application for Cabazitaxel Intravenous Powder (generic for Jevtana Kit) for the 60mg/1.5mL (40mg/mL) strength.
- Read more about NATCO Announces Approval of its ANDA for Cabazitaxel Intravenous Solution
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/natco-announces-approval-of-its-anda-for-cabazitaxel-intravenous-solution
No comments:
Post a Comment